EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

Intermediate AMD: If you have intermediate AMD in one or both eyes, AREDS 2 supplements may help prevent it from turning into late-stage AMD, which causes significant vision loss. Late AMD in One Eye: ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

Faricimab should be readministered with caution in patients who develop mild intraocular inflammation with a previous dose of ...

WALTHAM, Mass. - Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.7 billion market cap biotech company showing impressive revenue growth of 162% over the last twelve months, today announced that the ...

About SYFOVRE® (pegcetacoplan injection) SYFOVRE ® (pegcetacoplan injection) is the first-ever approved therapy for geographic atrophy (GA). By targeting C3, SYFOVRE is designed to provide ...

SolidddVision Smartglasses mimic a fly's eye structure to fill in missing vision for macular degeneration sufferers.

Phone apps for people with low vision can also be a big help, Mortazavi says. These include magnification apps like ...